EUVIMEDEUVIMED entdecken
EditorialKommentar

ADAM17 as a promising molecular target for organ protection in antihypertensive therapy

Alexander E Berezin iD

American Journal of Hypertension · 01.09.2026 · 39 (9) · 1055-1058

DOI: 10.1093/ajh/hpag071 ↗

Kurz gefasst

Editorial in der Zeitschrift American Journal of Hypertension, online erschienen am 02.07.2026. Verfasst von Alexander E Berezin. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine II, Paracelsus Medical University Salzburg, Salzburg, Austria. Die Arbeit nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

ADAM17angiotensin receptor type 1 blockersangiotensin receptorsangiotensin-converting enzyme 2angiotensin-converting enzyme inhibitorsblood pressurehypertension

Autor:innen und Institutionen

  • Division of Cardiology, Department of Internal Medicine II, Paracelsus Medical University Salzburg, Salzburg, Austria.

ORCID-Profile: Alexander E Berezin

Zitieren

APA

Berezin, A. E. (2026). ADAM17 as a promising molecular target for organ protection in antihypertensive therapy. American Journal of Hypertension, 39(9), 1055-1058. https://doi.org/10.1093/ajh/hpag071

Vancouver

Berezin AE. ADAM17 as a promising molecular target for organ protection in antihypertensive therapy. American Journal of Hypertension. 2026;39(9):1055-1058. doi:10.1093/ajh/hpag071

BibTeX
@article{Berezin2026,
  author = {Berezin, Alexander E},
  title = {ADAM17 as a promising molecular target for organ protection in antihypertensive therapy},
  journal = {American Journal of Hypertension},
  year = {2026},
  volume = {39},
  number = {9},
  pages = {1055--1058},
  doi = {10.1093/ajh/hpag071}
}
Kostenlos starten →